Remove ACE Inhibitor Remove Diabetes Remove Heart Failure
article thumbnail

Understanding the failings of yesterday to improve the outcomes of tomorrow: a CardioRenal story

The British Journal of Cardiology

2–4 The studies will be well-known to nephrologists and demonstrated that angiotensin-receptor blockers (ARBs) had anti-proteinuric effects and/or slowed the decline of kidney function in patients with diabetic kidney disease. Clinicians and health care systems must be encouraged to make use of these treatments.”

article thumbnail

The Management of Chronic Disease

Dr. Sanjay Gupta

So she went back in 4 weeks and this time saw another doctor who asked her to stop the inhalers and suggested that it could be her heart and organised a chest X-ray and blood tests. Medications that improve quality of life in heart failure for example include diuretics.

article thumbnail

Hyperkalemia

EMS 12-Lead

1] In their publication, Sclarovsky and Birnbaum discovered that with each grading escalation there is less salvageable myocardium and higher likelihood of heart failure at hospital discharge (an inversely proportional relationship). ACE inhibitors, or potassium-sparing diuretics), are particularly susceptible.

article thumbnail

SGLT-2 Inhibitors Show Mixed Results After Heart Attack

DAIC

However, researchers said the drug may be helpful in reducing heart failure risks, including hospitalization, following a heart attack. SGLT-2 inhibitors were initially approved to treat Type 2 diabetes by lowering blood sugar. About 32% had Type 2 diabetes.

article thumbnail

EMPACT-MI Trial Outcomes Reported at ACC24: SGLT-2 Inhibitors Show Mixed Results After Heart Attack

DAIC

While composite of death and heart failure hospitalizations was not significantly reduced, empagliflozin may help reduce heart failure risks after a heart attack, according to results from the EMPACT-MI trial presented on day one of the American College of Cardiology Scientific Sessions, ACC.24,